Lifeward

Marlborough, United States Founded: 2001 • Age: 25 yrs Listed
Developer of exoskeletons for individuals with spinal cord injuries and stroke rehabilitation

About Lifeward

Lifeward is a publicly listed company based in Marlborough (United States) founded in 2001. Lifeward has raised $27.88 million across 14 funding rounds from investors including Kreos Capital and Proseed Venture Capital Fund. The company has 80 employees. Lifeward has completed 1 acquisition, including AlterG. Its chief executive, as recorded, is Larry Jasinski. Its website golifeward.com draws about 24 thousand monthly visits. Lifeward offers products and services including ReWalk Personal Exoskeleton, AlterG Anti-Gravity Systems, ReStore Exo-Suit, and MYOLYN FES Cycling. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is REWALK ROBOTICS LTD. Its competitors include Ekso Bionics, Myomo and ROAM Robotics; 3 of its 3 listed competitors have raised funding.

Company details

Developer of exoskeletons for individuals with spinal cord injuries and stroke rehabilitation. The company offerings include the rewalk personal exoskeleton, restore exo-suit, and myocycle FES systems for rehabilitation, recovery, and more to address physical disability.

  • Headquarters Marlborough, United States
  • Employees 80
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website golifeward.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Rewalk Robotics Ltd.
Operational Areas
Key Metrics
  • Annual Revenue
    $22.03 M (USD)
    -14.14
    as on Dec 31, 2025
  • Net Profit
    -$19.91 M (USD)
    31.19
    as on Dec 31, 2025
  • EBITDA
    -$16.56 M (USD)
    -5.38
    as on Dec 31, 2025
  • Total Equity Funding
    $27.88M (USD)

    in 14 rounds

  • Latest Funding Round
    $11.16M (USD), Post-IPO

    Jul 2026

  • Investors
  • Employee Count
    80
  • Investments & Acquisitions

Products & Services of Lifeward

Lifeward offers a comprehensive portfolio of products and services, including ReWalk Personal Exoskeleton, AlterG Anti-Gravity Systems, ReStore Exo-Suit, and MYOLYN FES Cycling.

ReWalk Personal Exoskeleton
Exoskeleton

Device enabling walking for spinal cord injury patients.

AlterG Anti-Gravity Systems
Rehabilitation Equipment

Systems for reduced-gravity training in injury recovery.

ReStore Exo-Suit
Exo-Suit

Suit assisting movement for stroke and brain injury rehabilitation.

MYOLYN FES Cycling
Therapy Device

Cycling system for neurological condition therapy and exercise.

Apps and channels of Lifeward

its YouTube channel Lifeward has 5.72K subscribers and 30 videos.

Lifeward
YouTube 5.72K subscribers 30 videos Science & Technology
Open channel

Videos from Lifeward

The most watched videos on Lifeward's YouTube channel, Lifeward (5.72K subscribers). Click a video to play it here.

ReWalk Test Session Demo Video
31.9K views
ReWalk 7 Has Arrived!
11.7K views
ReWalker Homestory: Cathleen Teil 2/4
4.1K views
Hello NEO! Introducing the newest member of the AlterG Family
3.3K views

More on Lifeward.

Funding Insights of Lifeward

Lifeward has successfully raised a total of $27.88M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $11.16 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $27.88M
  • Total Rounds 14
  • Last Round Post-IPO β€” $11.16M
  • First Round $7M

    (Jul 2011)

  • Investors Count 2

Latest 10 of 14 funding rounds of Lifeward with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2026$11.16MPost-IPO––
–
Mar 2026$20MPost-IPO––
–
Jan 2025$5MPost-IPO––
–
Feb 2021$40MPost-IPO––
–
Dec 2020$8MPost-IPO––
–
Jun 2020$4.5MPost-IPO––
–
Jun 2019$5MPost-IPO––
–
Apr 2019$4.25MPost-IPO––
–
May 2018$5MPost-IPO––
–
Jan 2016$12MDebt – Venture––
Valuation history

2 investors in total: 2 institutional.

Investors in Lifeward

Lifeward has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Kreos Capital and Proseed Venture Capital Fund.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture debt is provided to growth-stage companies across multiple sectors.
1998kreoscapital.comLondon, United Kingdom
proseed.co.il
Premium access

Investor details for Lifeward

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Lifeward

34 people are tracked at Lifeward (17 in leadership, 17 in team); the tracked headcount is 80.

NameRoleGroup
Larry Jasinski
CEO & MDLeadership
David Hexner
Vice President Of Research And DevelopmentLeadership
Chad Woodmancy
Sales Director, US MedicalLeadership
Matthew Rudden
Vice President OperationsLeadership
Michael Coe
Director Of Sales OperationsLeadership
Jeannine Lynch
Vice President Of Strategy And Market AccessLeadership
Hamid Moshtaghi
Managing DirectorLeadership
Miri Pariente
Vice President Of Operations, Regulatory And QualityLeadership
Judy Kula
Vice President Human Resources & Customer ServiceLeadership
Jill Butler
Director Of Clinical DevelopmentLeadership
Keith Rose
Director Medical AffairsLeadership
Efrat Varsano
Qa/ra DirectorLeadership
Michael M.
VP Of TechnologyLeadership
Mela Ikanovic
Stellvertretende:r General Manager:inLeadership
Almog Adar
Vice President Of FinanceLeadership
Joanne Ford Ms
Area Sales DirectorLeadership
Craig Peters
Vice President Of Sales -- United StatesLeadership
Michael Swaim
Regional Account ManagerTeam
Joe Cranch
Field Service Manager - InternationalTeam
Assunta Puerio
Contract ManagerTeam

14 more people are available in the full profile.

Premium access

Complete people profiles for Lifeward

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Lifeward

Lifeward is a publicly listed company on the NASDAQ with ticker symbol LFWD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date12 Sep 2014
  • Listed onNASDAQ: LFWD
  • Listed entityLifeward Ltd.
  • Exchange sectorHealth technology

Investments & Acquisitions by Lifeward

Lifeward has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AlterG.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Hardware and software solutions for rehabilitation are provided by AlterG.
alterg.comFremont, United States2005Aug 2023β€’β€’β€’β€’
Premium access

Complete acquisition details for Lifeward

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Lifeward

5 dated milestones of Lifeward across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lifeward is founded.
  2. Funding First funding round of $7.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires AlterG.
  5. Funding Latest funding round, Post-IPO, of $11.2M.

Competitors of Lifeward

Lifeward has 3 listed competitors in our database, 3 of them funded. They include Ekso Bionics, Myomo and ROAM Robotics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
eksobionics.com2005United States$24.37M56
Exoskeletons for medical rehabilitation and industrial productivity are provided.
myomo.com2004Boston, United States$17.21M80
Robotic arms are provided for mobility and rehabilitation support.
roamrobotics.com2016San Francisco, United States$12M16
Wearable robotic exoskeletons are developed for industrial and military applications.
Premium access

Detailed competitors of Lifeward

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lifeward

The website of Lifeward (golifeward.com) receives about 24K visits a month.

  • Monthly visits
    24K

    ▼ 15.7% vs previous month

Similar websites

Websites whose visitors overlap most with Lifeward. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
rehabpub.com
rehabpub.com
100%
#3,365,605–
cda-amc.ca
100%
156.6K#295,290View details
christopherreeve.org
77%
119.3K#378,243View details
msktc.org
msktc.org
72%
#290,913–

Top companies in Orthopedics

3 companies that operate in the same segment as Lifeward (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lifeward

Premium access

Complete news archive for Lifeward

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lifeward

Lifeward was founded in 2001 and raised its 1st funding round 10 years after it was founded.

Lifeward is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.

Larry Jasinski is the CEO of Lifeward, as recorded in our data.

Lifeward is a funded company, having raised a total of $27.88M across 14 funding rounds to date. The company's 1st funding round was a Debt – Venture of $12M, raised on Jul 2011.

Lifeward has 80 employees.

Annual revenue of Lifeward is $22.03M as on Dec 31, 2025.

Developer of exoskeletons for individuals with spinal cord injuries and stroke rehabilitation. The company offerings include the rewalk personal exoskeleton, restore exo-suit, and myocycle FES systems for rehabilitation, recovery, and more to address physical disability.

Lifeward's top competitors include Myomo, Ekso Bionics and ROAM Robotics.

Lifeward offers ReWalk Personal Exoskeleton, AlterG Anti-Gravity Systems, ReStore Exo-Suit, and MYOLYN FES Cycling.

Yes, Lifeward is publicly traded on NASDAQ under the ticker symbol LFWD.

Lifeward has made 1 acquisition, including AlterG.

Lifeward has 2 investors. Key investors include Kreos Capital, and Proseed Venture Capital Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available